Kanamycin clinical trials
How each study uses Kanamycin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 13 Feb 1973 · KANTREX · ANDA 061655 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Kanamycin
- 2
Studies by the year they started
3 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
IUATLD, Inc (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Japan Multinational Trial Organization (1)
Often tested with
Tested in the same studies.
Pyrazinamide (2) · Isoniazid (2) · Clofazimine (1) · Ethambutol (1) · Prothionamide (1) · Levofloxacin (1) · Bedaquiline (1) · Rifampin (1)
Studies
Open first, then newest update. How each study uses Kanamycin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TBCompletedPhase 3IUATLD, IncNCT02409290Written as Kanamycin
- Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat TuberculosisCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00816426Written as Kanamycin
- Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic AntibioticsCompletedPhase 3Japan Multinational Trial OrganizationNCT00508690Written as kanamycin/metronidazole
As the comparator · 1 — what is tested is compared with Kanamycin
Codes
What other systems call Kanamycin · ClinicalTrials.gg INT007704
- MeSH (NLM) D007612KanamycinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) RUC37XUP2PKANAMYCINConfirmed FDA, Wikidata
- Wikidata Q421951kanamycinConfirmed FDA, Wikidata
- NCI Thesaurus C65997KanamycinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007612 | Kanamycin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | RUC37XUP2P | KANAMYCIN | Confirmed FDA, Wikidata |
| Wikidata | Q421951 | kanamycin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C65997 | Kanamycin | One source FDA |
Also registered as kanamycin a (UNII EQK9Q303C5 · RxNorm 1727573) and kanamycin a sulfate (UNII J80EX28SMQ · RxNorm 1300476).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.